Topic: Is patient self-management a key to improved patient outcomes, increased medication adherence and reduced adverse drug events?
Date: Tuesday, January 26, 2016
This Medication Safety Quality Improvement Organizations (QIN-QIOs), patients/beneficiaries, families and caregivers, partners, and healthcare practitioners.(LAN) Event was open to Quality Innovation Network-
Patient self-management may contribute to improved patient outcomes, quality of care and safety. Additionally, adverse drug events (ADE) continue to be a driver of healthcare costs and adverse outcomes, but there are interventions that may contribute to decreased ADEs. This panel of expert speakers shared how patient self-testing for anticoagulation has demonstrated better time within therapeutic range and associated outcomes; evaluated DSME and support; and explored the relationship of improved outcomes through behavior change and patient engagement.
- Explain the process for utilizing and referring patients for anticoagulation point-of-care (POC) testing and Diabetes Self-Management Education (DSME) services.
- Describe patient behaviors associated with self-management and consider the role of self-management for improving medication adherence.
- Understand the “when, where and how” for DSME and anticoagulation POC testing and the patient/beneficiary perspective on utilization of these resources.
Slides & Recorded Presentation:
Meet the Speakers:
Jack E. Ansell, MD, MACP
Professor of Medicine, Hofstra-North Shore/LIJ School of Medicine
Medication Safety & Program Lead
Randolph B. Fenninger, JD
CEO, National Blood Clot Alliance
Marty Hatlie, JD
Project Patient Care, CEO
Rachel Digmann, Pharm.D., BCPS
Medication Safety & Program Lead, Telligen, Quality Innovation Network National Coordinating Center
Anita Thomas, Pharm.D
Medication Safety Lead, CMS Quality Improvement Organization